42 related articles for article (PubMed ID: 11175307)
1. Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria.
Rebuffat A; Harding CO; Ding Z; Thöny B
Hum Gene Ther; 2010 Apr; 21(4):463-77. PubMed ID: 19916803
[TBL] [Abstract][Full Text] [Related]
2. Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites - A Review.
Bose S; Mandal S; Khan R; Maji HS; Ashique S
Curr Drug Saf; 2024; 19(2):208-217. PubMed ID: 36999718
[TBL] [Abstract][Full Text] [Related]
3. Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system.
Ding Z; Harding CO; Rebuffat A; Elzaouk L; Wolff JA; Thöny B
Mol Ther; 2008 Apr; 16(4):673-81. PubMed ID: 18362925
[TBL] [Abstract][Full Text] [Related]
4. The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria.
Harding CO; Neff M; Wild K; Jones K; Elzaouk L; Thöny B; Milstien S
Mol Genet Metab; 2004 Jan; 81(1):52-7. PubMed ID: 14728991
[TBL] [Abstract][Full Text] [Related]
5. State-of-the-art 2003 on PKU gene therapy.
Ding Z; Harding CO; Thöny B
Mol Genet Metab; 2004 Jan; 81(1):3-8. PubMed ID: 14728985
[TBL] [Abstract][Full Text] [Related]
6. Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pah(enu2) mice.
Harding CO; Neff M; Jones K; Wild K; Wolff JA
J Gene Med; 2003 Nov; 5(11):984-93. PubMed ID: 14601136
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrobiopterin: biochemistry and pathophysiology.
Werner ER; Blau N; Thöny B
Biochem J; 2011 Sep; 438(3):397-414. PubMed ID: 21867484
[TBL] [Abstract][Full Text] [Related]
8. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.
Michals-Matalon K
Expert Opin Investig Drugs; 2008 Feb; 17(2):245-51. PubMed ID: 18230057
[TBL] [Abstract][Full Text] [Related]
9. Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin.
Christensen R; Alhonen L; Wahlfors J; Jakobsen M; Jensen TG
Exp Dermatol; 2005 Jul; 14(7):535-42. PubMed ID: 15946242
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of the phenylalanine metabolism in human keratinocytes by retroviral mediated gene transfer.
Christensen R; Kolvraa S; Jensen TG
Cells Tissues Organs; 2005; 179(4):170-8. PubMed ID: 16046863
[TBL] [Abstract][Full Text] [Related]
11. Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria.
Christensen R; Güttler F; Jensen TG
Mol Genet Metab; 2002 Aug; 76(4):313-8. PubMed ID: 12208136
[TBL] [Abstract][Full Text] [Related]
12. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
Thöny B; Ding Z; Martínez A
FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
[TBL] [Abstract][Full Text] [Related]
13. 'Mommy, why can't I have a hamburger like the other kids?'.
Harding CO
Gene Ther; 2000 Dec; 7(23):1969-70. PubMed ID: 11175306
[No Abstract] [Full Text] [Related]
14. Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes.
Christensen R; Kolvraa S; Blaese RM; Jensen TG
Gene Ther; 2000 Dec; 7(23):1971-8. PubMed ID: 11175307
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
